Correlation Between Inhibikase Therapeutics and Gemina Laboratories
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Gemina Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Gemina Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Gemina Laboratories, you can compare the effects of market volatilities on Inhibikase Therapeutics and Gemina Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Gemina Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Gemina Laboratories.
Diversification Opportunities for Inhibikase Therapeutics and Gemina Laboratories
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Inhibikase and Gemina is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Gemina Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gemina Laboratories and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Gemina Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gemina Laboratories has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Gemina Laboratories go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Gemina Laboratories
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 3.27 times less return on investment than Gemina Laboratories. But when comparing it to its historical volatility, Inhibikase Therapeutics is 1.25 times less risky than Gemina Laboratories. It trades about 0.11 of its potential returns per unit of risk. Gemina Laboratories is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 34.00 in Gemina Laboratories on September 3, 2024 and sell it today you would earn a total of 21.00 from holding Gemina Laboratories or generate 61.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Gemina Laboratories
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Gemina Laboratories |
Inhibikase Therapeutics and Gemina Laboratories Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Gemina Laboratories
The main advantage of trading using opposite Inhibikase Therapeutics and Gemina Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Gemina Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gemina Laboratories will offset losses from the drop in Gemina Laboratories' long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Gemina Laboratories vs. Therapeutic Solutions International | Gemina Laboratories vs. Alpha Cognition | Gemina Laboratories vs. Vg Life Sciences | Gemina Laboratories vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |